In an epidemiologic study of 1,118 free-livinig volunteers, aged 25 to 79 (5152 ilmale, 566 female) drawn from eight counties of the Centrial Vallex, Californiia, the following determiniations were included: a medical history, blood pressulre, r-esting electrocardiogramil, plasma total cholesterol and glycerides (following a liglht, fat-free breakfast), and (wvleni lipids were considered to be elevated) plasma lipoproteins determined by electrophoresis. A sublgroup of the entire studv populationi (494 male, 503 female) free of overt diabetes anid electrocardiograplhic abnormalities, and with diastolic blood pressure not above 100 mm Hg, that was considered to be eliniically "normal," forms the basis of this report. Significanit sex differences for mean levels of total cholesterol xvere absent or of small magniitude at all age decades up to anid including the seventh. In contr-ast, glyceride levels for mein were significantlv higlher thani for womeni aged 25-59, aind differences were substantial. Beyond the seventh decade, females had higher mean levels of both plasma total cholesterol and glvcerides.
lipid abnormalities and (in prospective studies) to the atherogenicity of specific lipid elevations. The prospective Framingham study' indicated that plasma total cholesterol was the best predictor, among the parameters measured, of risk of subsequent coronary heart disease. Plasma glycerides were not measured, however, and attempts were not made at that time to place hyperlipidemic individuals in various classifications, such as those currently recognized.3 Several studiesa 4 have suggested that plasma glycerides may be at least as closely correlated with ischemic heart disease as is cholesterol; in these studies, lipid was measured on groups of patients with demonstrated coronary heart disease, and the investigations were not prospective. Schaefer5 conducted a study in Manhattan on 205 men and 228 women who were healthy, ambulatory adults without diagnosable ischemic heart disease. The study was selective, in that the participants were drawn from individuals visiting a hospital laboratory for procedures requiring a sample of fasting blood. Median plasma triglyceride levels for men appeared to exceed those for women in most age decades, but tests for statistical significance,'if carried out, were not reported. Nichols6) summarized findings by Gofman's group indicating that men generally have higher concentrations than women of the glyceriderich very low-density lipoproteins. The populations studied were relatively small groups of nonfasting individuals.
Heinle and associates7 have recently used modern technics to examine in detail the plasma lipoprotein status of 126 patients (101 males, 25 females) with coronary artery disease demonstrable by coronary cineangiogram. Fifty-four percent had an abnormal plasma lipoprotein pattern (80% for patients under 50), with an almost equal distribution between type II pattern (elevated betalipoproteins) and type IV pattern (elevated pre-beta-lipoproteins). These authors pointed out that many of the type IV group had normal total-cholesterol levels, so that a measurement of plasma cholesterol alone would not have detected their abnormality.
Circulation, Volumie XLV, January 1972 They concluded that "the incidence of both type II and type IV patterns in the general population, and more particularly the frequency with which these are due to mutations, has not yet been determined." It seems clear from this study that individuals with elevated fasting plasma glyceride levels should not be neglected in the search for the coronary-prone. A large study by Garcia-Palmieri and coworkers,s involving 9,814 Puerto Rican urban and rural men aged 45-64 years, indicated significantly higher levels of both plasma cholesterol and fasting glycerides in the urban men. The rural-urban difference was more striking for glvcerides, especially for men aged 45-54 (means, 127 and 171 mg/ 100 ml, respectively). Women were not included in this study, and typing of lipoprotein abnormalities was not attempted.
A recent report by Page and others" concludes: "Our results, based on the definition of coronary heart disease by cinearteriography, show that definite relationships exist among incidence of coronary heart disease, age, total cholesterol and total triglycerides, with less definite ones between free cholesterol and phospholipids for a specific group of 450 male patients referred to the Cleveland Clinic because of suspected coronary heart disease . . .-. The relationships were strong enough to be of aid in discriminating coronary heart disease from normal; the most useful being age, total cholesterol and triglycerides." Again, women were not examined, and lipoprotein typing was not attempted.
When the opportunity arose in October 1969 to study a volunteer population in Modesto, California, we sought to provide information about lipoprotein abnormalities that was not available from any existing reports. In addition, we sought confirmation of certain conclusions that had already been drawn from earlier studies. A moderate-sized population of free-living people was studied, containing both men and women aged 25-79. Both cholesterol and glycerides were measured by carefully standardized methods on blood drawn following a fat-free breakfast, and the prevalence of hyperlipoproteinemic types was determined, with the aid of agarose gel electrophoretic patterns. The following report covers some aspects of the results obtained, with particular emphasis on malefemale differences.
Methods

Recruitment
The aim of the study was to examine approximately 100 males and 100 females from each age decade, with particular emphasis upon the critical years 30 to 60. For this purpose, announcements were maade by televisioni anid in newspapers, covering eight California counties -Alpine, Amador, Calaveras, Mariposa, Merced, SaII joaquin, Stanislaus, and Tuolumne. Participants wvere invited to telephone one of three offices of the Central California Heart Associationi, located at Stockton, Modesto, anid Merced. Both men and wvomen were accepted into the study, and appointments made, provided volunteers were aged 25-79, and were, to their knowledge, free of heart disease and high blood pressure. Approximately 1,800 acceptable volunteers phoned in anid were placed in age-decade groups in the order in which they telephoned until the quota for a given decade was considered to be full, after which no further individuals of that age group were entered into the study.
On this basis about 1,200 participants were given appointments for examination, confirmed bv letter. Only 20 of these failed to attend. A total of 1,180 persons presented themselves for test.
Blood was drawn and analyzed on 1118 of thern; the loss of 62 persons at this stage was due to disqualification of the subject as a result of his not following the food-intake instructions, difficulty in obtaining venous blood, or discoverv during interview that the participant in fact was aw"are *NorIiial participatds are those with 15o history of treatment for diabetes, withooit electrocaidiographic abniormalitiies, antd with diai,tolic blood pressllre of 100 mm Ilg or below. of a previous myocardial infarction or of high blood pressure. Table 1 indicates that difficulty was expe ienced in recruiting the desired numbers of subjects in the 25-29 and 70-79 age groups. However, good participation wvas experienced in the 30-69-year age groups. The distribution by age of the two sexes was wvell matched; males were aged 47.0 + 12.8 years (mean + SD, n = 552), females 48.8 + 13.1 years (n 566).
Specific inquiry about race and ethnic origin of participants was not made. Negro participation was very lowv, however, probably less than a dozen people, and less than 30 participanits had Spanish surnames.
The examinations wvere held at the Scenic General Hospital, Modesto, during a period of 3 weeks. Participants were givxen appointments between 7 MxI and 2 Pxi, 6 days per week, at the rate of about 80 per day. Each subject attended with a completed questionnaire that he had received earlier by mail. After registering, he proceeded through the following stations: (a) complete physical, including historv, height, weight, and blood pressure readings; (b) blood drawing; (c) a computer-analyzed electrocardiogram;"' (d) spirometric measuremeents; (e) chest X-rays; anid (f) coniventionial electrocardiogram. A summary of resuilts of the tests wvas seiit to the participant's personal phvsician at a later date.
Plasma Lipid and Lipoprotein Measurements
Participanits were asked by letter to confine their food intake on the morniing of their tests to no more than two slices of drv toast and a glass of fruit juice. This request vas reinforced wvhenever possible by a telephone call on the evening before the test appointment. As a fturther check, each subject wvas asked to describe his breakfast that morning, while blood vas being drawvn, and his reply was noted. The fewx participants wvho had niot adhered to the restrictionis were excludled from the population described hereini.
Ten milliliters of venous blood was drawxn friom each participant from an arm vein, with minimal stasis, inlto a tube containing 10 mg of (ethylenedinitrilo) tetraacetic acid (EDTA). The plasma obtained after prompt cenitrifugation was divided into twvo aliquots, one frozen, for determination of total cholesterol and glycerides, the other kept at 4 C for lipoprotein electrophoresis of those plasmas vith elevation of either lipid.
Plasma lipids were detei-mined simultaneously from a single zeolite-treated isopropanol extract, using AutoAnalyzer methods N-24a (total cholesterol) and N-70 (glyceride by fluorometry) . 11 The reproducibility of the methods used was checked by running a frozen plasma standard (with lipid levels close to the upper limits of normal set for this study) periodically during the analyses. Results (mean SD) for this standard were: total cholesterol, 286 8.1 mg/ 100 ml (n = 71); glycerides, 203 8.0 mg/100 ml (n = 70). Coefficients of variation were 2.8% and 3.9%, respectively. An attempt was also made to assess the accuracy of the analytical procedures by an independent and reliable mass standardiza-tion12 of total cholesterol (following saponification) and of triglycerides, in the frozen standard. Results indicated a total-cholesterol content of 276 mg/ 100 ml, and a triglyceride content of 177 mg/100 ml (means of two). The somewhat lower value for triglyceride by mass determination was regarded as reasonable since the small quantities of monoglycerides and diglycerides in plasma are also measured in the fluorometric procedure for total plasma glycerides. In view of the consistent proximity of the standard, run after each 20 samples, to the correct result, our sample data seem to be of generally good quality. Satisfactory results were also obtained by using a "low" standard plasma with total-cholesterol level of 183 mg/ 100 ml and triglyceride level of 44 mg/ 100 ml.
Lipoprotein electrophoresis on agarose gel'3 was performed, using the refrigerated plasma sample, on the samples that had total-cholesterol levels equal to or greater than 275 mg/ 100 ml, or glyceride levels equal to or greater than 200 mg/ 100 ml, or both. Electrophoretograms were stained for lipid with Oil Red 0, and scanned using a Densicord desitometer with integrator. Each electrophoretic run included eight samples and a standard plasma; the areas under the curves for alpha-, beta-, and pre-beta-lipoprotein bands were expressed relative to the corresponding areas obtained for a standard plasma containing 210 mg/ 100 ml of cholesterol and 95 mg/ 100 ml of triglyceride. This procedure helped to minimize staining and other differences between electrophoretic runs.
Classification of Hyperlipoproteinemic Patterns
Those subjects showing plasma total-cholesterol levels of 275 mg/100 ml or above or glyceride levels of 200 mg/ 100 ml or above or both were arbitrarily considered to be hyperlipoproteinemic, regardless of age. The lipoprotein patterns of these individuals (171 of 1,118 participants) were classified according to the scheme suggested by Fredrickson and associates3 with the realization that many of the elevations represented acquired and nonfamilial disorders of lipid metabolism rather than genetically determined abnormalities, for which this classification was primarily devised. Because of the scale of the study, and in view of the absence of data from Circulation, Volume XLV, January 1972 family members, a modification of the original criteria of Fredrickson's group for assignment into the various lipoprotein types was utilized. The criteria which we applied were as follows:
Normal. Total-cholesterol values below 275 mg/ 100 ml and glycerides below 200 mg/ 100 ml.
Type II. Total cholesterol 275 mg/100 ml or above and glycerides below 200 mg/ 100 ml; absence of chylomicrons "floating beta-lipoprotein" on lipoprotein electrophoresis. Type III. Presence of "floating beta" lipoprotein," demonstrated by electrophoretic examination of the very low-density fraction of fasting whole plasma (all individuals considered to have a broad beta-band on electrophoresis, or having simultaneous elevation of both total cholesterol and glycerides, were asked to return for this procedure in April 1970).
Type IV. Glycerides at or above 200 mg/ 100 ml and total cholesterol below 275 mg/ 100 ml; absence of chylomicrons or "floating betalipoprotein" on lipoprotein electrophoresis. Type V. Glycerides at or above 200 mg/ 100 ml; distinct chylomicron band and prominent prebeta-lipoprotein band on lipoprotein electrophoresis.
Not classified. Cholesterol at or above 275 mg/ 100 ml and glycerides at or above 200 mg/ 100 ml; absence of chylomicrons and "floating beta-lipoprotein" on lipoprotein electrophoresis.
Normal and Abnormal Participants
The total population examined (1,118) was divided into a subgroup designated "normal" in this report (997) and another designated "abnormal" (121). The abnormal group contained subjects with the following conditions: (a) a history of having been treated for diabetes; (b) diastolic blood pressure greater than 100 mm Hg, as measured during the study; and (c) electrocardiographic abnormalities, as determined during the study.* All other participants constituted the normal subgroup, which is the primaryv subject of this report.
Data Collection
The data was stored on an on-line IBM computer 360 model 50 (ACME) located at *Individuals with the following electrocardiographic findings were excluded from the normal group: QRS duration greater than 100 msec; atrial flutter or fibrillation; Wolf-Parkinson-White pattern; and q waves in appropriate leads and meeting standard criteria for myocardial infarction. No subjects were excluded from the normal group on the basis of T-wave morphology. A detailed report of the standard and computer-analyzed electrocardiographic findings of this study is currently in preparation. Staniford University Medical Center. Each subject was described by both numeric and nonnumeric data. Typical niumeric data are those derived from plasma lipid and anthropometric measures, while typical nonniumeric data are niame, address, occupation, and sex. The data were stored on file inl ACME, and on a back-up tape.
Statistical Methods
Various estimates of populationi pal ameters, such as means, variances, and correlations, were computed from standard programs in ACME. The distribution of plasma total-cholesterol and glyceride concentrationis, as an aid in ascertaininig the underlying probability density function and to demonstrate the extent of skewniess, was derived from standard histographic and cumulative frequency polygonal programs in ACME. Other descriptive statistical variables, suclh as the median and percentiles, were computed from the same programs.
The total-cholesterol and glvceride data were approximated by a lognormal distribution. Tests of significance (t-tests) were obtained from standard programs in ACME. Covariance wxas analyzed by means of the biomedical programs,'4 with an IBM 360/67 computer.
Results
The numbers of male and female participants examined are shown in table 1 by age decade, with data for all participants and the normal subgroup. Table 2 shows the numbers of male and female participants who had certain clinical abnormalities at the time of the study. Clinical abnormalities were approximately equally distributed by sex.
The age and sex distribution of plasma totalcholesterol concentration for the normal population is shown in table 3 . In men, cholesterol rose gradually with advancing age, peaked in the seventh decade, and then declined. In women, on the other hand, an age peak was not observed. No significant sex differences in cholesterol concentrations were present. In the eighth decade, however, concentrations in omen were substantially higher than those in men.
Unilike the cholesterol concentrations, glyceride concenitrationis were significantly higher in men than in women for the normal population (table 4) . Furthermore, the magnitude of these differences xvas substantial. In men, glyceride concentrations peaked in the sixth decade, that is, a decade earlier than the cholesterol peak, and then declined. In wxomen, glycerides, like cholesterol showed no age peak.
The percentages of the normal population exceeding certain commonly used limits of normal for plasma total cholesterol and glycerides are shown in tables 5 and 6. Rather large numbers of both males and females exceeded the lower of the twvo limits both for total cholesterol (240 mug/ 100 ml) and for glycerides (150 mg/100 ml). The number of males with values exceeding or equal to the higher of the two glyceride limits (200 mg/ 100 ml) was particularly impressive (15%). Table 7 gives the 50th percentile (median) and 95th percentile values for total cholesterol and glycerides by age and sex. The 50th percentile values for cholesterol (both male and female) approximate those for the means (table 3) ; however, this is not true for the corresponding glyceride figures (table 4) , indicating that the glyceride distribution is more highly skewed. Figures 1 to 4 show the distribution of total-cholesterol and glyceride concentrations for both men and women of the normal population. Various correlations (normal population) between age and total cholesterol and age and Only a very modest correlation was found between plasma cholesterol and glycerides among men and women. Table 9 gives the mean + SD for age, plasma total cholesterol, and glycerides for the entire population and for the normal and abnormal subgroups. The abnormal subgroup was significantly older than the normal for both men and women (P< 0.001). The abnormal men and women showed higher plasma glycerides than normal men and women (P< 0.01 and P < 0.02, respectively). Plasma cholesterol was higher in abnormal than in normal women (228 vs 208 mg/100 ml, P <0.001), but this parameter was not significantly different for the two subgroups of men.
The absence of a significant difference in total-cholesterol concentration between men and women prior to age 69 led us to inquire whether or not significant sex differences existed in the distribution of plasma cholesterol between the two major cholesterol-bearing lipoproteins, that is, alpha and beta. We therefore examined the areas under the alpha-, beta-, and pre-beta-peaks for men and women having either type II or IV electrophoretic pattern. The results (table 10) indicate that alpha-lipoprotein areas were significantly greater in women than in men with both type II and type IV patterns. Significant sex differences were not observed for either betaor pre-beta-lipoprotein levels, however, in either abnormal group. Distribution by concentration (mg/100 ml) of plasma total cholesterol in normal males. Each x represents 1% of the normal male population (494). Also shown are the cumulative percentages of the male population included up to a given concentration (asterisks) and figures for the percentage of the male population having cholesterol levels within a given concentration range. The diagram was generated by the ACME computer. Data similar to those in figure 1 , for plasma glyceride levels in normal males (494). Tables 11 and 12 show the frequency by age group of five electrophoretic types of hyperlipoproteinemia for the normal men and women, respectively. Type II patterns were observed more commonly in women than in men, whereas the reverse was true for type IV patterns. In men, peak frequencies were observed in the seventh decade for type II patterns and in the sixth decade for type IV patterns. In women, on the other hand, the frequency of type II patterns rose steadily with age; the same was generally true for type IV patterns except that the frequency in the fourth decade was slightly higher than in the fifth and sixth decades. The age and sex distribution of type II and type IV patterns is in agreement with the age and sex distribution of cholesterol and glyceride concentrations; this is not surprising in view of the manner in which cholesterol and glyceride concentrations were used to assist in assigning electrophoretic types.
No instances of type I, and only two of type III and of type V were encountered among the normal individuals. Since only 35 of the 45 possible subjects with type III patterns Data similar to those in figure 1 , for plasma glyceride levels in normal females (503).
returned for restudy, it is possible that some of the 10 who did not return may have had type III patterns. Applying the rate found (two confirmed cases among 35 suspected cases) to the remaining 10, we doubt whether we could have missed more than one, or at most two, such individuals. Thus, it is unlikely that the maximum prevalence of type III disease could have exceeded 0.4% in this population. A small number of individuals were considered to have elevations of both betaand pre-betalipoproteins and therefore did not fall conveniently into either the type II or the type IV category. Rather than arbitrarily assigning these individuals, we have chosen to designate them as "not classified."
Discussion
The sample of free-living population studied consisted of volunteers, and therefore is Only a very small minority of participants had Spanish surnames. Removal from the total group of those participants with overt diabetes, electrocardiographic abnormalities, and diastolic blood pressures greater than 100 mm Hg left a subgroup of 997 individuals (494 males and 503 females) designated "normal" who were the primary subjects for this study. Our findings (table 3 and figs. 1 and 2) confirm those of previous studies in demonstrating the lack of an important sex difference in total-cholesterol concentrations.3 13 The higher incidence of coronary artery disease in men, therefore, cannot be attributed simply to their having higher plasma total-cholesterol levels than women. The fall in mean cholesterol concentration in the eighth decade in men has been ascribed to the selective removal from the population of those men bearing the highest cholesterol levels. Such a phenomenon apparently does not occur in women judging by the lack of an agedependent peak cholesterol concentration in females.
It has been suggested that plasma betacholesterol is more atherogenic than alphacholesterol and that the sex difference in the attack rate of coronary artery disease could result from higher beta-cholesterol levels in men. 6 The absence of a sex difference for total cholesterol would be explained if a reciprocal sex difference in alpha-cholesterol existed. This hypothesis has never been rigorously tested in a population survey. Unfortunately, technical considerations precluded direct measurement of alphaand beta-cholesterol in all subjects in the present study. However, the absence of a significant sex difference in the staining intensity of the beta-lipoprotein bands, as judged by densitometric scanning of the electrophoretograms, does not support this hypothesis. The same data, however, do indicate that alpha-lipoprotein levels are somewhat higher in women than in men, as has been observed previously' in small groups. It is possible that alpha-lipoprotein exerts a protective influence against coronarv artery disease, but there is little direct evidence in support of this concept.
These considerations naturally draw attention to the rather impressive sex difference in mean plasma glyceride concentration wvhich xvas found in this population (table 4 and figs. :3 and 4). This observation, taken together x7ith the lack of a sex difference in cholesterol, is consistent with the concept that the male predominance in coronary disease is related to the higher glyceride concentrations which are present in men during those years when coronary atherosclerosis is developing. The drop in mean glyceride lex-els in the seventh and eighth decades could be considered to result from the death at an earlier age of those male individuals bearing the highest glyceride levels.
The plasma glyceride levels of both men and wxomen hax-e seldom been studied in large, free-living populations. Hoxxx ever, Schaefer's! data on a sample of 433 persons in M1anhattan agree xwith our findings in indicating higher levels for men up to the seventh decade, notxvithstanding that his absolute xalues xxere considerably loxxwer than ours at comparable ages. Recent data from Puerto Rico,8 although confined to males, do indicate relatively high fasting plasma glyceride levels, comparable xvith ours, especially for urban residents. Studies by the Donner Laboratorx group l'" on 16 males and 16 females aged 335-30 years have indicated considerably higher mean plasma concentrations of very loxdensity lipoproteins in the men; this also is consistent with our glyceride findings. Hoxxevel, antecedent dietary fat intake was not controlled in the Donner Laboratory study. Our results are in agreement xvith those from the Stockholm prospective studv in wvhich 6,464 subjects xvere examined xvith respect to fasting serum triglycerides and total cholesterol. 17 In that monumental investigation, mean plasma total-cholesterol levels xvere essentially identical for males and females aged 20-50 X ears; hoxvzever, mean male plasma triglvcer-ide levels were about 23i higher than female lev-els for the 23-35-year age glroups.
The unimpressix e correlation of plasma glycerides with plasma total cholesterol for the entire normal population (table (S) is in agreement with Schaefer's findingy and is not uniexpected.
To the best of our knowledge the prev-alence of the xarious types of hvperlipoproteinemia in a large, free-lix ineg populationi hias not been prexviouslv determined. We recognize the limitations inherent in our attempt to provide such information in this study. In x iexxT of the scale of the studx , it xvas inecessarxl to dexise a modification of the original criteria of Fredrickson and associates: for classification of hyperlipoproteinemias. The major differences between our criteria and tlheirs xwere (1) our use of a non-age-adjusted plasma cholesterol cutoff to 275 mg/100 mil, rather thani age-adjusted beta-cholesterol concentrations, in the diagnosis of type II patterns; (2) oulr use of a nion-age-adjusted plasma triglyceride cutoff of 200 mg/ 100 ml in the diagnosis of type IV patterns; and (3) the fact that xx e did not make use of data obtained from family members. W7e recomnize the arbitrariiness of our cutoff points; however, in xiew of the lack of generally agreed-upon upper limits of normal for plasmna lipid lex els. w,e felt justified in choosing lex els that many authorities xx ould probably accept as undesirably high regardless of age. Had xve chosen to apply the more stringent criteria for trigix ceride levels used by Fredrickson and associates: the prevalence of type IV patterns wvould clearly be higher than reported here. In addition, since the original criteria of Fredriickson's group. do not necessarily exclude patients from the type II category by virtue of elevated pre-beta-lipoprotein concentrations. some of the individuals sv7hom xve have left unclassified wvould probablv be included in the ty-pe II category in their system. Although xvTe realize that the exact prevxalence of the x-arious hvperlipoproteinemias remnains some-xxThat uincertain, we nevertheless believe that certain of our conclusionis are reasonablv xvell Circulation. I'oiu,e XLI'. 1 Tu 1-established: namely, that hyperlipoproteinemia is quite common in this population; that types I, III, and V are far less common than types II and IV; and that type IV is relatively more common than type II, at least in men.
A recent report from the Framingham study has again called attention to the fact that prebeta-lipoprotein, like plasma cholesterol, is a predictor of the risk of developing coronary heart disease.'8 The authors of that report chose to emphasize the superiority of cholesterol in this regard; however, if, as indicated by our results, the prevalence of type IV hyperlipoproteinemia considerably exceeds that of typC II, pre-beta-lipoprotein could still be an important precursor of coronary disease. Thus, for example, Heinle and associates7 found the prevalence of type II and type IV hyperlipoproteinemias to be equal in patients with coronary disease proved by coronary arteriography. The criteria for diagnosis of these conditions were similar, although not identical, to ours. These results, taken with our data on a normal population, suggest that prebeta-lipoprotein is less atherogenic than betalipoprotein, but that it nevertheless makes an equal contribution to the overall burden of coronary heart disease. Proof of this hypothesis will require rigorous prospective studies using standardized diagnostic criteria.
The infrequent occurrence of type III and V patterns in the general population is suggested by our findings. While the latter pattern could be identified without difficulty from study of the plasma lipid levels and the electrophoretogram, final identification of the type III pattern was a more exacting proposition. It became clear that a considerable proportion of agarose electrophoretograms thought to show a broad beta-band3 lx were not in fact derived from plasmas containing floating beta-lipoprotein-one of the final criteria for assignment to this class. In fact, onily two of 35 suspected plasmas actually showed detectable amounts of floating betalipoprotein, for a total prevalence in the normal population of between 0.2 and 0.4%. This finding suggests that the type III condition may have been reported more Circulation, Volurme XLV, January 1972 frequently than was justified in some previous work when ultracentrifugation was not a part of the identification procedure. We believe that "broadening" of the beta-band may sometimes occur during storage of plasma at 40 C, so that assignment to the type III class may be hazardous in the absence of ultracentrifugal evidence.
